Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemifloxacin vs clarithromycin in quadruple therapy for Helicobacter pylori eradication
IRCT2012102011054N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gemifloxacin and clarithromycin in Helicobacter pylori infection (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Apr 2013; status: completed.
02
Drugs
gemifloxacinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT2012102011054N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012102011054N2.